{
  "authors": [
    {
      "author": "Emmanuelle Tavernier"
    },
    {
      "author": "Emilie Chalayer"
    },
    {
      "author": "Jérôme Cornillon"
    },
    {
      "author": "Anne Pouvaret"
    },
    {
      "author": "Jean-Alain Martignoles"
    },
    {
      "author": "François Casteillo"
    },
    {
      "author": "Jérémy Terreaux"
    },
    {
      "author": "Elisabeth Daguenet"
    },
    {
      "author": "Denis Guyotat"
    }
  ],
  "doi": "10.1186/s13104-018-3533-0",
  "publication_date": "2018-07-05",
  "id": "EN113208",
  "url": "https://pubmed.ncbi.nlm.nih.gov/29970140",
  "source": "BMC research notes",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "We describe the case of a mantle cell lymphoma patient who developed a fulminant hepatitis following oxaliplatin-containing intensive chemotherapy and autologous transplantation. This clinical manifestation was secondary to a very severe SOS/VOD. The patient did not exhibit the usual risk factors and presented a non-classical form with major cytolysis, thus puzzling SOS/VOD diagnosis in this context."
}